The short answer
No use has passed JIVANA's study-level evidence review yet.
- Evidence and scope
- Research gathered — evidence review pending
This status does not grade the ingredient for every goal, outcome, or person.
- Important limitation
- No efficacy conclusion has passed JIVANA's study-level review yet. The linked research index is for discovery, not a benefit claim.
- Before deciding
- Identity, dose, interactions, product quality, and regulatory status still require review. Do not use this provisional page to decide whether to take it.
02 / EVIDENCE
What the research says
We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.
This research-index page is live so the topic, source trail, and evidence boundaries are visible. Individual studies have not yet passed the JIVANA extraction and review process, so we do not manufacture an efficacy conclusion or research count from broad search results.
Unscreened discovery appendix—not evidence5,668 candidate publicationsSearch run: Aug 21, 2026
Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.
03 / SOURCES
Start with the source material
The live search is for discovery only. Search-result counts change and are not included in the audited totals above.
Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
- Effects of combined versus single supplementation of creatine and beta-alanine on aerobic and anerobic performance: a systematic review and network meta-analysis.Bai X, Xu T · 2026 · Journal of the International Society of Sports Nutrition · PMID 42384726Open on PubMed ↗
- Effects of carnosine supplementation on physical endurance: a placebo-controlled randomized clinical trial.O'Toole TE, Wingard CJ, Bariess SK et al. · 2026 · Journal of the International Society of Sports Nutrition · PMID 42308284Open on PubMed ↗
- Selected immunoendocrine and performance adaptations to upper-body plyometric training and β-alanine supplementation in male swimmers.Gao H, Yu X, Guo Z · 2026 · Journal of the International Society of Sports Nutrition · PMID 42218755Open on PubMed ↗
- Efficacy and hepatotoxicity of Psoralea corylifolia L.: A meta-analysis and machine learning assessment in postmenopausal osteoporosis.Yang H, Tang R, Ren Y et al. · 2026 · Journal of ethnopharmacology · PMID 42331197Open on PubMed ↗
- Oral semaglutide for weight loss and liver fibrosis in overweight and obesity: A randomized controlled trial.Katrevula A, Kalapala R, Agrawal S et al. · 2026 · Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · PMID 41066034Open on PubMed ↗
- Meal Replacement Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents with Severe Obesity.Rode JB, Wolf JM, Bolan PJ et al. · 2026 · Childhood obesity (Print) · PMID 42281167Open on PubMed ↗
- 144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.Wedemeyer H, Aleman S, Blank A et al. · 2026 · Journal of hepatology · PMID 41966308Open on PubMed ↗
- Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.Sun HC, Zhu XD, Shen F et al. · 2026 · Lancet (London, England) · PMID 42624156Open on PubMed ↗
- Enhanced metabolic flexibility links Mediterranean diet with cognition: interim findings from a randomized controlled trial.Cruz M, Martínez-Huélamo M, Yubero-Serrano EM et al. · 2026 · Food & function · PMID 42504863Open on PubMed ↗
- Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.Wu YL, Hochmair M, Yang Y et al. · 2026 · The New England journal of medicine · PMID 42223087Open on PubMed ↗
- In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia.Vafai SB, Täubel J, Ashdown T et al. · 2026 · The New England journal of medicine · PMID 42187087Open on PubMed ↗
- Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.Zhou J, Mahadevan D, Parekh J et al. · 2026 · Cancer chemotherapy and pharmacology · PMID 42581203Open on PubMed ↗
04 / EXPERT CONTEXT
Expert context—not evidence
Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.
No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.